There is no abstract in this article.
Rajagopal K. Applications of Artificial Intelligence in Drug Design, Discovery and Development. J App Pharm Sci, 2023; 13 (Suppl 1): i-ii. http://doi.org/10.7324/JAPS.2023.9.1ed
Harrer S. Artificial intelligence for clinical trial design. Trends in Pharmacological Sciences, 2019; 40:577–591. http://doi.org/10.1016/j.tips.2019.05.005
Jane Wakefield, Artificial intelligence-created medicine to be used on humans for first time. https://www.bbc.com/news/technology-51315462, 30, Jan, 2020.
Lamberti M.J. A study on the application and use of artificial intelligence to support drug development. Clinical Therapeutics.2019;41:14141426. http://doi.org/10.1016/j.clinthera.2019.05.018
Miles J., Walker A. The potential application of artificial intelligence in transport. IEE Proceedings-Intelligent Transport Systems, 2006;153:183–198
Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK. Artificial intelligence in drug discovery and development. Drug Discovery Today. 2021; 26(1): 80-93. http://doi.org/10.1016/j.drudis.2020.10.010.
Pu L. eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates. BMC Pharmacology and Toxicology, 2019;20:2. http://doi.org/10.1186/s40360-018-0282-6
Yang X. Concepts of artificial intelligence for computer-assisted drug discovery. Chemical Reviews. 2019; 119:1052010594. http://doi.org/10.1021/acs.chemrev.8b00728
Zhang L. From machine learning to deep learning: progress in machine intelligence for rational drug discovery. Drug Discovery Today, 2017; 22: 1680–1685. http://doi.org/10.1016/j.drudis.2017.08.010
https://www.genengnews.com/news/insilico-gains-fdas-first-orphan-drug-designation-for-ai-candidate/, 10, Feb, 2023.
Year
Month
In silico design of new ketorolac bioisosteres as anti-inflammatory agents
César D. Gamarra-Sánchez, Cristhian N. Rodriguez-Silva, Angella Cordova-Muñoz, Lucero Asmad-Cruz, Carmen R. Silva-Correa, Víctor E. Villarreal-La TorreProteomics in Drug Discovery